Delivery Order SPE2DB24D3013-SPE2DB25FFHQJ

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,222.40 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 1, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,227.12 firm fixed-price delivery order covers the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC serves...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,354.20 firm fixed-price contract is for the procurement of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,504.50 firm fixed-price contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,591.70 firm fixed-price contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,483.36 firm fixed-price delivery order contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a performance period through May 12, 2023 and was awarded on May 11, 2023. Amerisourcebergen, a for-profit organization, is the prime contractor and there is no...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,320.92 Firm Fixed Price Delivery Order contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract has an ultimate completion date of September 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,532.76 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a diabetes management medication. The award has an ultimate completion date of August 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $2,252.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used in the management of diabetes. The contract has a firm fixed price and an ultimate completion date of November 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.82 Firm Fixed Price Delivery Order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFHQJ
    Delivery Order

This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,191.32, is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of December 31, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization based in Conshohocken, Pennsylvania. The company maintains significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000, respectively, for the provision of a broad range of pharmaceutical products and medical supplies to support federal healthcare programs, including military treatment facilities and veterans' healthcare.

Generated 3/31/25, 9:36 AM